Early Publishing of Clinical Trial Data Striking the Balance between Patent Protection & the Wider Public Interest
Professor of Biotechnology Law, Jur. Dr., LL.M., M.I.C.L.
Centre for Information and Innovation Law (CIIR) (Germany)
- Success of recent changes
- Is the industry complying in practise?
- Outcome switching
- Secondary filings
- Second Medical Use Patents
- Position of the key stakeholders
- Real consequences of publishing data earlier
- The perspective of innovators